Moreover, epigenetic signals or cytokines, such as TGF-β, secreted locally by glioma cells can dysregulate the expression of natural-killer group 2, member D, an activator of NK cells, thereby inhibiting tumor-specific cytolysis and preventing the immune response (107, 108). The gene discussed is TGFB1; the disease is neoplasm.